Live stream: The Power of Patient Generated Data

Dr Ali K Yetisen is a Senior Lecturer and an Associate Professor of Chemical Engineering at Imperial College London. His research focuses on nanotechnology, photonics, sensors, and biomaterials, particularly the development and validation of biophotonic medical devices for monitoring of high-risk individuals in clinical or point-of-care settings.

His talk titled "The Medical Tricorder" will illustrate current and future wearable sensor technologies and help you sort fact from fiction.

Dr James Kinross is a consultant colorectal surgeon at Imperial College London, with a specialist surgical interest in laparoscopic and robotic surgery for colon cancer and benign conditions of the gut. He researches the gut microbiome and colon cancer, collaborating with researchers in the USA and across Europe in order to find new ways to diagnose and treat diseases of the colon by engineering the gut microbiome to promote health.

Dr James Kinross will speak about the future of personalised medicine made possible by "Listening to the Patient's Gut Bacteria".

Dr Yoram Levanon is a pioneer of the vocal analysis of emotions and health. He was Chief Scientific Officer of Israeli company, Beyond Verbal, and will describe the continuous monitoring of health status through AI-Human vocal interactions.

Paul Wicks, Ph.D., is a neuropsychologist and independent consultant in digital health, clinical trials, rare disease, and patient centricity. For 13 years he led the R&D team at PatientsLikeMe, an online community for people over 700,000 people living with medical conditions. Paul sits on the editorial boards of the BMJ, BMC Medicine, JMIR, Digital Biomarkers and The Patient. In 2011 he was awarded MIT Technology Review’s TR35 “Humanitarian of the Year” award, recognized as a TED Fellow in 2012, and joined the inaugural FLIER Program at the Academy of Medical Sciences in 2019.

His talk will examine a number of case studies such as the #WeAreNotWaiting movement that hacked their own diabetes devices, the ALS lithium study that saw an activated group of patients take trials into their own hands, and consider where the future of patient-harnessed data is taking us.